Mr. Philippe Dubuc reports

THERATECHNOLOGIES ANNOUNCES THE RESIGNATION OF ONE OF ITS DIRECTORS, MR. GARY LITTLEJOHN

Gary Littlejohn has resigned from the board of directors of Theratechnologies Inc. and as a member of its audit committee, effective immediately.

"I want to thank Gary for his important contributions to Theratechnologies as a director since joining the company in October, 2018," said Dawn Svoronos, chair of the board at Theratechnologies. "Gary was a member of the audit committee since May, 2019, and a member of the compensation committee from May, 2019, until March, 2023, including acting as chair of this committee from August, 2019, to March, 2023. We value the expertise and commitment he brought to his director and committee roles during his tenure." Consistent with past practices, the board of directors of the company will assess whether it will appoint a new member to fill this vacancy before the next annual meeting of shareholders.

About Theratechnologies Inc.

Theratechnologies is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs.

We seek Safe Harbor.